|
1
|
Cojocaru M, Cojocaru IM, Silosi I and
Vrabie CD: Manifestations of systemic lupus erythematosus. Maedica
(Buchar). 6:330–336. 2011.PubMed/NCBI
|
|
2
|
Bombardier C, Gladman DD, Urowitz MB,
Caron D and Chang CH: Derivation of the SLEDAI. A disease activity
index for lupus patients. The Committee on Prognosis Studies in
SLE. Arthritis Rheum. 35:630–640. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Manson JJ and Rahman A: Systemic lupus
erythematosus. Orphanet J Rare Dis. 1:62006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lipsky PE: Systemic lupus erythematosus:
An autoimmune disease of B cell hyperactivity. Nat Immunol.
2:764–766. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
LeBien TW and Tedder TF: B lymphocytes:
how they develop and function. Blood. 112:1570–1580. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
DiLillo DJ, Matsushita T and Tedder TF:
B10 cells and regulatory B cells balance immune responses during
inflammation, autoimmunity and cancer. Ann N Y Acad Sci.
1183:38–57. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fillatreau S: Novel regulatory functions
for Toll-like receptor-activated B cells during intracellular
bacterial infection. Immunol Rev. 240:52–71. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mauri C: Regulation of immunity and
autoimmunity by B cells. Curr Opin Immunol. 22:761–767. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blair PA, Norena LY, Flores-Borja F,
Rawlings DJ, Isenberg DA, Ehrenstein MR and Mauri C: CD19
(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy
individuals but are functionally impaired in systemic Lupus
Erythematosus patients. Immunity. 32:129–140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yanaba K, Bouaziz JD, Matsushita T, Magro
CM, St Clair EW and Tedder TF: B-lymphocyte contributions to human
autoimmune disease. Immunol Rev. 223:284–299. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mauri C and Bosma A: Immune regulatory
function of B cells. Annu Rev Immunol. 30:221–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pistoia V: Production of cytokines by
human B cells in health and disease. Immunol Today. 18:343–350.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang M, Rui K, Wang S and Lu L: Regulatory
B cells in autoimmune diseases. Cell Mol Immunol. 10:122–132. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pillai S, Mattoo H and Cariappa A: B cells
and autoimmunity. Curr Opin Immunol. 23:721–731. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hochberg MC: Updating the American College
of Rheumatology revised criteria for the classification of systemic
lupus erythematosus. Arthritis Rheum. 40:17251997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Davies R, Vogelsang P, Jonsson R and Appel
S: An optimized multiplex flow cytometry protocol for the analysis
of intracellular signaling in peripheral blood mononuclear cells. J
Immunol Methods. 436:58–63. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Candando KM, Lykken JM and Tedder TF: B10
cell regulation of health and disease. Immunol Rev. 259:259–272.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mosser DM and Zhang X: Interleukin-10: New
perspectives on an old cytokine. Immunol Rev. 226:205–218. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Linton PJ, Harbertson J and Bradley LM: A
critical role for B cells in the development of memory CD4 cells. J
Immunol. 165:5558–5565. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Crawford A, Macleod M, Schumacher T,
Corlett L and Gray D: Primary T cell expansion and differentiation
in vivo requires antigen presentation by B cells. J Immunol.
176:3498–3506. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bouaziz JD, Yanaba K, Venturi GM, Wang Y,
Tisch RM, Poe JC and Tedder TF: Therapeutic B cell depletion
impairs adaptive and autoreactive CD4+ T cell activation
in mice. Proc Natl Acad Sci USA. 104:20878–20883. 2007; View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Homann D, Tishon A, Berger DP, Weigle WO,
von Herrath MG and Oldstone MB: Evidence for an underlying CD4
helper and CD8 T-cell defect in B-cell-deficient mice: Failure to
clear persistent virus infection after adoptive immunotherapy with
virus-specific memory cells from muMT/muMT mice. J Virol.
72:9208–9216. 1998.PubMed/NCBI
|
|
23
|
Bergmann CC, Ramakrishna C, Kornacki M and
Stohlman SA: Impaired T cell immunity in B cell-deficient mice
following viral central nervous system infection. J Immunol.
167:1575–1583. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miyagaki T, Fujimoto M and Sato S:
Regulatory B cells in human inflammatory and autoimmune diseases:
From mouse models to clinical research. Int Immunol. 27:495–504.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sims GP, Ettinger R, Shirota Y, Yarboro
CH, Illei GG and Lipsky PE: Identification and characterization of
circulating human transitional B cells. Blood. 105:4390–4398. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peng H, Wang W, Zhou M, Li R, Pan HF and
Ye DQ: Role of interleukin-10 and interleukin-10 receptor in
systemic lupus erythematosus. Clin Rheumatol. 32:1255–1266. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yuan W, DiMartino SJ, Redecha PB, Ivashkiv
LB and Salmon JE: Systemic lupus erythematosus monocytes are less
responsive to interleukin-10 in the presence of immune complexes.
Arthritis Rheum. 63:212–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng SG: Transforming growth factor-beta
level: Indicator for severity of disease and organ damage in
patients with systemic lupus erythematosus. J Rheumatol.
37:1983–1985. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cairns AP, Crockard AD and Bell AL:
Interleukin-10 receptor expression in systemic lupus erythematosus
and rheumatoid arthritis. Clin Exp Rheumatol. 21:83–86.
2003.PubMed/NCBI
|
|
30
|
Li YM, Chen ZQ, Yao X, Yang AZ, Li AS, Liu
DM and Gong JQ: mRNA expression of chemokine receptors on
peripheral blood mononuclear cells and correlation with clinical
features in systemic lupus erythematosus patients. Chin Med Sci J.
25:162–168. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cui HD, Qi ZM, Yang LL, Qi L, Zhang N,
Zhang XL, Du SY and Jiang Y: Interleukin-10 receptor expression and
signalling were down-regulated in CD4 (+) T cells of lupus
nephritis patients. Clin Exp Immunol. 165:163–171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Figueroa-Vega N, Galindo-Rodriguez G,
Bajaña S, Portales-Pérez D, Abud-Mendoza C, Sánchez-Torres C and
González-Amaro R: Phenotypic analysis of IL-10-treated,
monocyte-derived dendritic cells in patients with systemic lupus
erythematosus. Scand J Immunol. 64:668–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bennett AL, Chao CC, Hu S, Buchwald D,
Fagioli LR, Schur PH, Peterson PK and Komaroff AL: Elevation of
bioactive transforming growth factor-beta in serum from patients
with chronic fatigue syndrome. J Clin Immunol. 17:160–166. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Becker-Merok A, Eilertsen GØ and Nossent
JC: Levels of transforming growth factor-beta are low in systemic
lupus erythematosus patients with active disease. J Rheumatol.
37:2039–2045. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng SG, Wang J, Wang P, Gray JD and
Horwitz DA: IL-2 is essential for TGF-beta to convert naive
CD4+CD25+ cells to
CD25+Foxp3+ regulatory T cells and for
expansion of these cells. J Immunol. 178:2018–2027. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
van Hoek B: The spectrum of liver disease
in systemic lupus erythematosus. Neth J Med. 48:244–253. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
El-Emshaty HM, Nasif WA and Mohamed IE:
Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The
Immune and Inflammatory Response. Dis Markers. 2015:7072542015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Taylor A, Verhagen J, Blaser K, Akdis M
and Akdis CA: Mechanisms of immune suppression by interleukin-10
and transforming growth factor-beta: The role of T regulatory
cells. Immunology. 117:433–442. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
el-Houseini ME, Mohammed MS, Elshemey WM,
Hussein TD, Desouky OS and Elsayed AA: Enhanced detection of
hepatocellular carcinoma. Cancer Control. 12:248–253. 2005.
View Article : Google Scholar : PubMed/NCBI
|
